Author

S. E. P. Smith

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

A. Stratiievska· 1 shared C. M. Adeyemi· 1 shared D. N. E. P. Sather· 1 shared E. N. Senning· 1 shared E. P. Gniffke· 1 shared J. D. Lautz· 1 shared J. K. Walker· 1 shared K. B. Tsegay· 1 shared

Activity by Year

2018-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Stratiievska

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2

K. B. Tsegay, C. M. Adeyemi, E. P. Gniffke, D. N. E. P. Sather, J. K. Walker, S. E. P. Smith

The paper screens 2701 approved drugs to find those inhibiting SARS-CoV-2 spike protein binding to ACE2, identifying 56 compounds with >90% inhibition and modeling their docking.

bioRxiv · Apr 8, 2021Pharmacology & Toxicology

Reciprocal regulation among TRPV1 channels and phosphoinositide 3-kinase in response to nerve growth factor

A. Stratiievska, S. Nelson, E. N. Senning, J. D. Lautz, S. E. P. Smith, S. E. Gordon

The paper shows TRPV1 channels and PI3K reciprocally regulate each other in response to NGF, with TRPV1's N-terminal ARD enhancing PI3K activity.

bioRxiv · Jun 13, 2018Biochemistry